DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C.

Information source: Hoffmann-La Roche
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hepatitis C, Chronic

Intervention: peginterferon alfa-2a (40KD) [PEGASYS] (Drug); Copegus (Drug); Copegus (Drug); peginterferon alfa-2a (40KD) [PEGASYS] (Drug)

Phase: Phase 4

Status: Active, not recruiting

Sponsored by: Hoffmann-La Roche

Official(s) and/or principal investigator(s):
Clinical Trials, Study Director, Affiliation: Hoffmann-La Roche, +1 973 235 5000

Summary

This 4 arm study will compare the efficacy and safety of PEGASYS induction and maintenance dosing, versus standard fixed dosing in combination with Copegus,and the efficacy and safety of higher dose versus standard dose Copegus in combination with PEGASYS. Patients with chronic hepatitis C genotype 1 infection of high viral titer, and baseline body weight >=85kg, will be randomized to one of 4 groups, to receive a)PEGASYS 180 micrograms sc weekly plus Copegus 1200mg po daily, b)PEGASYS 180 micrograms sc weekly plus Copegus 1400-1600mg po daily, c)PEGASYS 360 micrograms sc weekly (induction) followed by 180 micrograms sc weekly (maintenance) plus Copegus 1200mg po daily or d)PEGASYS 360 micrograms sc weekly (induction) followed by 180 micrograms sc weekly (maintenance) plus Copegus 1400-1600mg po daily. Following 48 weeks treatment, there will be a 24 week period of treatment-free follow-up. The anticipated time on study treatment is 3-12 months, and the target sample size is 500+ individuals.

Clinical Details

Official title: A Randomized, Double-Blind Study of the Effect on Sustained Viral Response, and the Safety, of Standard or 360 ug PEGASYS Induction Dosing in Combination With Standard or Higher Dose Copegus in Treatment-Naive Chronic Hepatitis C Patients Weighing >85kg With Genotype 1 High Viral Titer Infection

Study design: Treatment, Randomized, Double Blind (Subject, Investigator), Active Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome: SVR

Secondary outcome:

SVR

Virological response

AEs, laboratory parameters, Beck Depression Inventory

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- adult patients, >=18 years of age;

- CHC infection, genotype 1;

- HCV RNA >=400,000 IU/mL;

- baseline body weight >=85kg;

- liver biopsy (within 24 months of first dose) with results consistent with CHC.

Exclusion Criteria:

- previous treatment with interferon, ribavirin, viramidine, levovirin, HCV polymerase

or protease inhibitors;

- other forms of liver disease, including liver cancer;

- human immunodeficiency virus infection.

Locations and Contacts

BRUXELLES 1200, Belgium

GENT 9000, Belgium

BRUXELLES 1030, Belgium

BRUXELLES 1070, Belgium

BRUXELLES 1000, Belgium

CAIXA 18618-970, Brazil

SAO PAULO 01307, Brazil

CAMPINAS 13083-888, Brazil

SALVADOR 40110-170, Brazil

PORTO ALEGRE 90035-003, Brazil

PORTO ALEGRE 91350-200, Brazil

JUIZ DE FORA 36036-330, Brazil

SAO JOSE DO RIO PRETO 15090-000, Brazil

ODENSE 5000, Denmark

LILLE 59037, France

CLERMONT-FERRAND 63000, France

CLICHY 92118, France

BERLIN 13353, Germany

HAMBURG 20246, Germany

KIEL 24105, Germany

FRANKFURT AM MAIN 60590, Germany

FREIBURG 79106, Germany

KÖLN 50937, Germany

BONN 531105, Germany

DÜSSELDORF 40225, Germany

GIESSEN 35392, Germany

TÜBINGEN 72076, Germany

HEIDELBERG 69120, Germany

PECS 7654, Hungary

GYULA 5700, Hungary

DEBRECEN 4012, Hungary

BUDAPEST 1097, Hungary

BUDAPEST 1083, Hungary

BEKESCSABA 5600, Hungary

GYOR 9024, Hungary

ROTTERDAM 3015 GD, Netherlands

WROCLAW 51-124, Poland

LODZ 91-347, Poland

BYDGOSZCZ 85-030, Poland

KIELCE 25-317, Poland

CHORZOW 41-500, Poland

WARSZAWA 01-201, Poland

SANTURCE 00909, Puerto Rico

SAN JUAN 00936-5067, Puerto Rico

PONCE 00716, Puerto Rico

BUCHAREST 022328, Romania

CLUJ-NAPOCA, Romania

BUCHAREST 010825, Romania

CONSTANTA, Romania

BUCHAREST 021105, Romania

BUCHAREST 030303, Romania

TIMISOARA, Romania

IASI 700111, Romania

MOSCOW 105229, Russian Federation

MOSCOW 143420, Russian Federation

SMOLENSK 214006, Russian Federation

ST PETERSBURG 194044, Russian Federation

JALOSLAVE --, Russian Federation

MOSCOW 119881, Russian Federation

STAVROPOL 355017, Russian Federation

MOSCOW 11/5, Russian Federation

MOSCOW 115446, Russian Federation

NIZHNY NOVGOROD 603022, Russian Federation

MOSCOW 103287, Russian Federation

MOSCOW 117333, Russian Federation

SAMARA 443011, Russian Federation

STOCKHOLM, Sweden

UPPSALA 75185, Sweden

SOUTHAMPTON SO16 6YD, United Kingdom

NEWCASTLE UPON TYNE NE7 7DN, United Kingdom

LONDON SE5 9RS, United Kingdom

LONDON SW17 0QT, United Kingdom

BIRMINGHAM, Alabama 35294, United States

HUNTSVILLE, Alabama 35801, United States

ANCHORAGE, Alaska 99508, United States

EDMONTON, Alberta T6G 2B7, Canada

PHOENIX, Arizona 85006, United States

VANCOUVER, British Columbia V6Z 2K5, Canada

SAN DIEGO, California 92115, United States

SAN DIEGO, California 92154, United States

SAN DIEGO, California 92123, United States

LANCASTER, California 93534, United States

SACRAMENTO, California 95817, United States

SAN LUIS OBISPO, California 93401, United States

LOS ANGELES, California 90095, United States

LOS ANGELES, California 90045, United States

FRESNO, California 93702, United States

VENTURA, California 93003, United States

SAN MARCOS, California 92069, United States

LA JOLLA, California 92037-1030, United States

SAN DIEGO, California 92103-8465, United States

AURORA, Colorado 80045, United States

ENGLEWOOD, Colorado 80113, United States

WASHINGTON, District of Columbia 20010, United States

WASHINGTON, District of Columbia 20037, United States

SARASOTA, Florida 34243, United States

JACKSONVILLE, Florida 32209, United States

NORTH MIAMI BEACH, Florida 33162, United States

JACKSONVILLE, Florida 32256, United States

MIAMI, Florida 33136-1051, United States

ATLANTA, Georgia 30308, United States

MARIETTA, Georgia 30060, United States

AUSTELL, Georgia 30106, United States

HONOLULU, Hawaii 96817, United States

WINFIELD, Illinois 60190, United States

CHICAGO, Illinois 60637, United States

CHICAGO, Illinois 60612, United States

INDIANAPOLIS, Indiana 46202, United States

IOWA CITY, Iowa 52242-1081, United States

DES MOINES, Iowa 50312, United States

IOWA CITY, Iowa 52246, United States

LOUISVILLE, Kentucky 40202, United States

NEW ORLEANS, Louisiana 70112, United States

BATON ROUGE, Louisiana 70805, United States

WINNIPEG, Manitoba R3E 3P4, Canada

WORCESTER, Massachusetts 01068, United States

BOSTON, Massachusetts 02720, United States

YPSILANTI, Michigan 48197, United States

DETROIT, Michigan 48210, United States

PLYMOUTH, Minnesota 55446, United States

ST LOUIS, Missouri 63110, United States

KANSAS CITY, Missouri 64131, United States

ST LOUIS, Missouri 63104, United States

LEBANON, New Hampshire 03756, United States

EGG HARBOUR TOWNSHIP, New Jersey 08234, United States

VINELAND, New Jersey 08360, United States

BRONX, New York 10467, United States

MANHASSET, New York 11030, United States

WILLIAMSVILLE, New York 14221, United States

NEW YORK, New York 10029, United States

YONKERS, New York 10701, United States

NEW YORK, New York 10021, United States

ROCHESTER, New York 14618, United States

ASHEVILLE, North Carolina 28801, United States

CHAPEL HILL, North Carolina 27599-7080, United States

FAYETTEVILLE, North Carolina 28304, United States

HALIFAX, Nova Scotia B3H 2Y9, Canada

CLEVELAND, Ohio 44106, United States

CLEVELAND, Ohio 44109, United States

CINCINNATI, Ohio 45267, United States

TULSA, Oklahoma 74104, United States

OTTAWA, Ontario K1H 8L6, Canada

TORONTO, Ontario M5G 1L7, Canada

LONDON, Ontario N6A 5A5, Canada

TORONTO, Ontario M6H 3M1, Canada

TORONTO, Ontario M5G 1X5, Canada

MEDFORD, Oregon 97504, United States

LANCASTER, Pennsylvania 17604-3200, United States

PHILADELPHIA, Pennsylvania 19107, United States

PHILADELPHIA, Pennsylvania 19104, United States

PITTSBURGH, Pennsylvania 15213, United States

CRANSTON, Rhode Island 02920, United States

PROVIDENCE, Rhode Island 02903, United States

COLUMBIA, South Carolina 29203, United States

WEST NASHVILLE, Tennessee 37205, United States

GERMANTOWN, Tennessee 38138, United States

DALLAS, Texas 75208, United States

FORT SAM HOUSTON, Texas 78234-3879, United States

DALLAS, Texas 75390, United States

HOUSTON, Texas 77030, United States

DALLAS, Texas 75246, United States

HOUSTON, Texas 77030, United States

SALT LAKE CITY, Utah 84121, United States

CHESAPEAKE, Virginia 23320-1706, United States

CHARLOTTESVILLE, Virginia 22906-0013, United States

RICHMOND, Virginia 23249, United States

ANNANDALE, Virginia 22003, United States

FAIRFAX, Virginia 22031, United States

TACOMA, Washington 98405, United States

VANCOUVER, Washington 98664, United States

SEATTLE, Washington 98104, United States

CASPER, Wyoming 82609, United States

CHEYENNE, Wyoming 82001, United States

Additional Information

Starting date: February 2007
Ending date: March 2009
Last updated: June 17, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008